[Current epidemiology of microbial low respiratory tract infections]

F Trémolières1

  • 1Service de médecine interne et des maladies infectieuses, hôpital Francois-Quesnay, 78200 Mantes-la-Jolie, France. f.tremo@noos.fr

Insights

Pneumonia is commonly caused by Streptococcus pneumoniae, Influenza A, Mycoplasma pneumoniae, Haemophilus influenzae, and Legionella pneumophila. Diagnosis of viral and atypical bacterial infections has improved with PCR, but clinical relevance is debated.

Area of Science:

  • Respiratory Medicine
  • Infectious Diseases
  • Microbiology

Context:

  • Pneumonia and acute bronchitis literature review reveals fragmented studies within established bacterial prevalence intervals.
  • Germ occurrence in respiratory infections varies geographically and temporally.
  • Commonly identified pathogens include Streptococcus pneumoniae, Influenza A, Mycoplasma pneumoniae, Haemophilus influenzae, and Legionella pneumophila.

Purpose:

  • To review current literature on the epidemiology of pneumonia and acute bronchitis.
  • To identify the most frequent bacterial and viral causative agents of pneumonia.
  • To assess the clinical utility of diagnostic methods like PCR for respiratory infections.

Summary:

  • Streptococcus pneumoniae is the most frequent cause of pneumonia in hospitalized patients, while Mycoplasma, Chlamydia, and viruses are more common in outpatients.
  • Staphylococcus and Enterobacteriaceae are observed in elderly patients with comorbidities.
  • Co-infections, often involving Streptococcus pneumoniae, are increasingly recognized, with the causal agent remaining unknown in 25-50% of cases.
  • Methicillin-resistant Staphylococcus aureus has been identified.
  • PCR has improved viral and atypical bacterial diagnosis, but its clinical relevance and epidemiological value are under scrutiny.
  • Research on acute bronchitis epidemiology remains stagnant, while bacterial exacerbation of COPD focuses on Haemophilus influenzae's role.

Impact:

  • Highlights the persistent challenges in identifying causative agents for pneumonia.
  • Questions the routine clinical application of advanced diagnostic tools like PCR for respiratory infections.
  • Underscores the need for further research into the epidemiology of acute bronchitis and the specific role of Haemophilus influenzae in COPD exacerbations.

Related Concept Videos

Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...